Primary ocular presentation of tuberous sclerosis - A case report

被引：3

作者：

Rajasekaran, Nancy M. ^{[1
]}

Horo, Saban ^{[1
]}

Kuriakose, Thomas ^{[1
]}

机构：

[1] Christian Med Coll & Hosp, Dept Ophthalmol, Vellore 632004, Tamil Nadu, India

来源：

INDIAN JOURNAL OF OPHTHALMOLOGY | 2019年 / 67卷 / 03期

关键词：

Aggressive retinal hamartoma; bevacizumab; fundus flurescein angiography; tuberous sclerosis; SECONDARY; THERAPY;

D O I：

10.4103/ijo.IJO_925_18

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

A 25-year-old man presented with decreased vision in the left eye with hypopigmented elevated subretinal lesion over the optic disk with abnormal vasculature, subretinal and retinal hemorrhages, and fluid in the macula. An area of high spike over the disk with corresponding orbital shadowing was seen on B scan ultrasonography. Fundus fluorescein angiography revealed abnormal vasculature. Systemic examination revealed facial angiofibroma, ashleaf spot, and dental pits with multiple cortical tubers on CT brain. Intravitreal injection of bevacizumab led to visual and tomographic improvement. Abnormal retinal vascularization and exudation in young individuals may be a presenting feature in tuberous sclerosis.

引用

页码：433 / 435

页数：3

共 13 条

[1] Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms [J].

Arbiser, JL ;

Brat, D ;

Hunter, S ;

D'Armiento, J ;

Henske, EP ;

Arbiser, ZK ;

Bai, XH ;

Goldberg, G ;

Cohen, C ;

Weiss, SW .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) :376-380

[2] PHOTOCOAGULATION FOR SEROUS DETACHMENT OF THE MACULA SECONDARY TO RETINAL ASTROCYTOMA [J].

BLOOM, SM ;

MAHL, CF .

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 1991, 11 (04) :416-422

[3] Photodynamic therapy with verteporfin to induce regression of aggressive retinal astrocytomas [J].

Eskelin, Sebastian ;

Tommila, Petri ;

Palosaari, Tapani ;

Kivela, Tero .

ACTA OPHTHALMOLOGICA, 2008, 86 (07) :794-799

[4] VITREOUS HEMORRHAGE COMPLICATING RETINAL ASTROCYTIC HAMARTOMA [J].

KROLL, AJ ;

RICKER, DP ;

ROBB, RM ;

ALBERT, DM .

SURVEY OF OPHTHALMOLOGY, 1981, 26 (01) :31-38

[5] Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature [J].

Mennel, Stefan ;

Meyer, Carsten H. ;

Peter, Silvia ;

Schmidt, Joerg C. ;

Kroll, Peter .

ACTA OPHTHALMOLOGICA SCANDINAVICA, 2007, 85 (02) :127-132

[6] Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis [J].

Nguyen-Vu, PA ;

Fackler, I ;

Rust, A ;

DeClue, JE ;

Sander, CA ;

Volkenandt, M ;

Flaig, M ;

Yeung, RS ;

Wienecke, R .

JOURNAL OF CUTANEOUS PATHOLOGY, 2001, 28 (09) :470-475

[7]

Osborne J.P., 1991, ANN NY ACAD SCI, V615, P125

[8] Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria [J].

Roach, ES ;

Gomez, MR ;

Northrup, H .

JOURNAL OF CHILD NEUROLOGY, 1998, 13 (12) :624-628

[9] Ophthalmic manifestations of tuberous sclerosis: a population based study [J].

Rowley, SA ;

O'Callaghan, F ;

Osborne, JP .

BRITISH JOURNAL OF OPHTHALMOLOGY, 2001, 85 (04) :420-423

[10] Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema [J].

Saito, Wataru ;

Kase, Satoru ;

Ohgami, Kazuhiro ;

Mori, Shohei ;

Ohno, Shigeaki .

ACTA OPHTHALMOLOGICA, 2010, 88 (03) :377-380

← 1 2 →